In the control-treated tumor, IL-1 signaling, including IL-1A, IL-1β, and IL-18, appeared to be the dominant cytokine-type ligand-receptor interaction between macrophages/granulocytes and CAFs (Figure 7A). The gene discussed is IL1A; the disease is neoplasm.